USPTO trademark

NORTHERA (DROXIDOPA) CAPSULES

RegisteredUSPTOWord and designClass 36Class 41Class 44

"NORTHERA (DROXIDOPA) CAPSULES" is a word and design mark owned by Lundbeck NA Ltd., filed at the USPTO on July 2, 2024. It is registered and covers classes 36, 41 and 44.

Get this data via the API
Official USPTO record
NORTHERA (DROXIDOPA) CAPSULES trademark as filed
As filed with the USPTO
Status
Registered
Since July 1, 2025
Filed
July 2, 2024
Registered
July 1, 2025
Expires
Not recorded
Application no.
98628720
Registration no.
7847765
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
3 classes
Ownership

Who owns NORTHERA (DROXIDOPA) CAPSULES

The owner and representative on file with the office.

Owner

Lundbeck NA Ltd.

Deerfield, United States

Representative

Maren C. Perry

King & Spalding LLP

Goods and services

What the mark covers

The products and services NORTHERA (DROXIDOPA) CAPSULES is filed for, grouped by Nice class.

  • Providing insurance and insurance reimbursement information; financial administration of patient reimbursement programs, namely, copay financial assistance programs; providing patient support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance information on insurance authorization forms, appeals and status, providing information on insurance-approved site-of-care facilities, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims

  • Providing a website via a global computer network featuring online, non-downloadable images, articles featuring quotes, video clips and videos featuring supportive personal stories all on the subject of health and neurogenic orthostatic hypotension

  • Medical information services, namely, providing medical information regarding neurogenic orthostatic hypotension caused by Parkinson's disease, multiple system atrophy and autonomic neuropathy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Notification of non-final action e-mailed

6 earlier steps on the official record.

FAQ

About NORTHERA (DROXIDOPA) CAPSULES

Who owns the trademark "NORTHERA (DROXIDOPA) CAPSULES"?

The USPTO trademark "NORTHERA (DROXIDOPA) CAPSULES" (application 98628720) is owned by Lundbeck NA Ltd.

What is the status of "NORTHERA (DROXIDOPA) CAPSULES"?

Its status at the USPTO is: registered.

When was "NORTHERA (DROXIDOPA) CAPSULES" registered?

It was registered on July 1, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NORTHERA (DROXIDOPA) CAPSULES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d293b-3aaf-7209-9678-acaef6aec2f9
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d293b-3aaf-7209-9678-acaef6aec2f9",
  "object": "trademark",
  "mark_text": "NORTHERA (DROXIDOPA) CAPSULES",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98628720",
  "filing_date": "2024-07-02",
  "nice_classes": [
    36,
    41,
    44
  ],
  "owners": [
    {
      "name": "Lundbeck NA Ltd.",
      "entity_id": null
    }
  ]
}